CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease

Gene

Volumn 540, Issue 2, 2014, Pages 183-190

  Bonadia, Luciana Cardoso ^a   De Lima Marson, Fernando Augusto ^a   Ribeiro, Jose Dirceu ^a   Paschoal, Ilma Aparecida ^a   Pereira, Monica Corso ^a   Ribeiro, Antonio Fernando ^a   Bertuzzo, Carmen Silvia ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

CFTR; Cystic fibrosis; Mutation

Indexed keywords

CHLORIDE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; SODIUM;

ACHROMOBACTER XYLOSOXIDANS; ADULT; ARTICLE; BACTERIAL COLONIZATION; BURKHOLDERIA CEPACIA; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL STUDY; COMORBIDITY; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; FEMALE; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL DISEASE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LUNG DISEASE; LUNG FUNCTION; MALE; MECONIUM ILEUS; MEDICAL RECORD; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUTATION RATE; NOSE POLYP; OSTEOPENIA; OUTCOME ASSESSMENT; OXYGEN SATURATION; PANCREAS DISEASE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; SWEAT TEST; YOUNG ADULT;

PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

CFTR; CYSTIC FIBROSIS; MUTATION;

ADOLESCENT; ADULT; CHLORIDES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; PSEUDOMONAS INFECTIONS; SEQUENCE DELETION; SEVERITY OF ILLNESS INDEX; SODIUM; STAPHYLOCOCCAL INFECTIONS; SWEAT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84896544980     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.02.040     Document Type: Article

References (22)

1. Amaral M.D., Kunzelmann K. Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis. Trends in Pharmacological Sciences 2007, 28:334-341.
2. American Thoracic Society (ATS) (Access in: 04.04.2012). http://www.thoracic.org/.
3. Bhalla M., Turcios N., Aponte V., Jenkins M., Leitman B.S., McCauley D.I., Naidich D.P. Cystic fibrosis: scoring system with thin-section CT. Radiology 1991, 179:783-788.
4. Cooper C., Robertson C., Hudson I., Phelan P. Variability of pulmonary function tests in cystic fibrosis. Pediatric Pulmonology 1990, 8:16-22.
5. Costantino L., Claut L., Paracchini V., Coviello D.A., Colombo C., Porcaro L., Capasso P., Zanardelli M., Pizzamiglio G., Degiorgio D., Seia M. A novel donor splice site characterized by CFTR m RNA analysis induces a new pseudo-exon in CF patients. Journal of Cystic Fibrosis 2010, 9:411-418.
6. Cystic Fibrosis Foundation Cystic Fibrosis Foundation Annual Patient Registry Report 2008, Cystic Fibrosis Foundation, Bethesda, MD.
7. Davis P.B. Cystic fibrosis since 1938. American Journal of Respiratory and Critical Care Medicine 2006, 173:475-482.
8. Dobbin C.J., Bye P.T.P. Adults with cystic fibrosis: meeting the challenge!. Internal Medicine Journal 2003, 33(12):593-597.
9. Farrel P.M. Improving the health of patients with cystic fibrosis through newborn screening. Advances in Pediatrics 2000, 49:79-115.
10. Haardt M., Benharouga M., Lechardeur D., Kartner N., Lukacs G.L. C-terminal truncations destabilize the cystic fibrosis transmembrane conductance regulator without impairing its biogenesis. Journal of Biological Chemistry 1999, 274(31):21873-21877.
11. Kanga J., Wilson J., Posson A. The efficacy of reported symptoms and physical findings in identifying children with clinically significant deteriorations of pulmonary function: a longitudinal study. Pediatric Pulmonology 1990, (Suppl. 5):258.
12. Koch C., Cuppens H., Rainisio M., Madessani U., Harms H., Hodson M., Mastella G., Navarro J., Strandvik B., McKenzie S. Comparison of major disease manifestations between patients with different classes of mutation. Pediatric Pulmonology 2001, 31(1):1-12.
13. Konstan M.W., Wagener J.S., VanDevanter D.R. Characterizing aggressiveness and predicting future progression of CF lung disease. Journal of Cystic Fibrosis 2009, 8(1):S15-S19.
14. O'Sullivan B.P., Freedman S.D. Cystic fibrosis. Lancet 2009, 373:1891-1904.
15. Raskin S., Phillips J.A., Krishnamani M.R.S. DNA analysis of cystic fibrosis in Brazil by direct PCR amplification from Guthrie cards. American Journal of Medical Genetics 1993, 46:665-669.
16. Riordan J.R., Rommens J.M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J.L., Drumm M.L., Iannuzzi M.C., Collins F.S., Tsui L.C. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989, 245:1066-1073.
17. Rodrigues R., Gabetta C.S., Pedro K.P., Valdetaro F., Fernandes M.I.M., Magalhães P.K.R., Januário J.N., Maciel L.M.Z. Cystic Fibrosis and Neonatal Screening 2008, 24 Sup. 4:S475-S484. Cad Saúde Publica, Rio de Janeiro.
18. Schwachmann H., Kulczychi L.L. Long term study of one hundred five patients with cystic fibrosis. American Journal of Diseases of Children 1958, 96:6-15.
19. Suarez-Kurtz G. Pharmacogenomics in admixed populations. Trends in Pharmacological Sciences 2005, 26:196-201.
20. Tuchman L.K., Schwartz L.A., Sawicki G.S., Britto M.T. Cystic fibrosis and transition to adult medical care. Pediatrics 2010, 125:566-573.
21. Zielenski J., Tsui L.-P. Cystic fibrosis: genotype and phenotype variations. Annual Review of Genetics 1995, 29:777-807.
22. Zielinski J., Rozmahel R., Bozon D., Kerem B., Grzelczk Z., Riordan J.R., Rommens J., Tsui L.C. Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics 1991, 10:214-228.